Lyra Therapeutics (LYRA) Misses Q3 EPS by 338c
Tweet
Share
E-mailGet Alerts LYRA Hot Sheet
Join SI Premium – FREE
Lyra Therapeutics (NASDAQ: LYRA) reported Q3 EPS of ($3.38).
For earnings history and earnings-related data on Lyra Therapeutics (LYRA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blue Owl leads $2.4 billion debt deal for Iren data center
- BiomX announces 1-for-10 reverse stock split effective Sept. 9
- Lobe Sciences upsizes private placement to $2.16M
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
